| Effect of portosystemic shunting on PGI2 and glucagon levels in humans. | |
| | |
MedLine Citation:
|
PMID: 8452403 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: This study determined if the proposed mediators of splanchnic blood flow, prostacyclin and glucagon, were elevated in patients with portal hypertension undergoing portal systemic shunts. SUMMARY BACKGROUND DATA: Chronic portal hypertension results in increased portal venous pressure and increased splanchnic blood flow. Animal studies have suggested prostacyclin or glucagon, potent vasodilators, as potential mediators of this increased flow. Correlative clinical studies have been difficult to perform due to the wide variation in degree of portal-systemic shunting and the frequent association of parenchymal liver disease in patients with cirrhosis. METHODS: The authors measured portal and systemic hemodynamics in PGI2 and glucagon levels in patients with portal hypertension due to cirrhosis (partial portal systemic shunt) and Budd-Chiari syndrome (complete portal systemic shunt) undergoing portal systemic shunts and in porto normotensive patients undergoing exploratory laparotomies. RESULTS: PGI2 levels in portal hypertension were significantly increased over normal, and prostacyclin in Budd-Chiari patients were increased significantly over patients with cirrhosis. Both PGI2 and portal venous pressure decreased significantly after portal systemic shunting, and prostacyclin levels correlated directly with portal venous pressure (R = 0.37, p < 0.05). CONCLUSIONS: This is the first evidence in humans supporting the hypothesis that PGI2 is elevated in portal hypertension and is related to both the degree of portal venous obstruction and portal pressure. PGI2 probably has a role in the abnormal splanchnic hemodynamics of human portal hypertension. |
| | |
Authors:
|
J V Sitzmann; K A Campbell; Y Wu; J L Cameron |
Related Documents
:
|
10684773 - Role of kupffer cells in the release of nitric oxide and change of portal pressure afte... 15808683 - Combination of hdaf-transgenic pig hearts and immunoadsorption in heterotopic xenotrans... 20492033 - Animal model of ascending aortic stenosis in rabbits without endotracheal intubation. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Annals of surgery Volume: 217 ISSN: 0003-4932 ISO Abbreviation: Ann. Surg. Publication Date: 1993 Mar |
Date Detail:
|
Created Date: 1993-04-15 Completed Date: 1993-04-15 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0372354 Medline TA: Ann Surg Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 248-52 Citation Subset: AIM; IM |
Affiliation:
|
Johns Hopkins Medical Institutions, Baltimore, Maryland 21205. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Blood Pressure Budd-Chiari Syndrome / blood, physiopathology, surgery Epoprostenol / blood* Female Glucagon / blood* Humans Hypertension, Portal / blood, physiopathology, surgery Intraoperative Period Male Middle Aged Portasystemic Shunt, Surgical* Postoperative Period Preoperative Care Regression Analysis |
| Grant Support | |
ID/Acronym/Agency:
|
HLB R29 39683/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
35121-78-9/Epoprostenol; 9007-92-5/Glucagon |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Benign biliary strictures. Surgery or endoscopy?
Next Document: Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vago...